Plus Therapeutics, Inc. (NASDAQ:PSTV) Q4 2024 Earnings Call Transcript March 27, 2025
Plus Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.67 EPS, expectations were $-0.51.
Operator: Good afternoon, ladies and gentlemen. Welcome to Plus Therapeutics’ Fourth Quarter and Full Year 2024 Results Conference Call. Before we begin, we want to advise you that over the course of the call, including any question-and-answer session, forward-looking statements will be made...
